Research ArticleOMERACT 2016 — International Consensus Conference on Outcome Measures in Rheumatology, Whistler, British Columbia, Canada, May 2016
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group
Louise Klokker, Peter Tugwell, Daniel E. Furst, Dan Devoe, Paula Williamson, Caroline B. Terwee, Maria E. Suarez-Almazor, Vibeke Strand, Thasia Woodworth, Amye L. Leong, Niti Goel, Maarten Boers, Peter M. Brooks, Lee S. Simon and Robin Christensen
The Journal of Rheumatology December 2017, 44 (12) 1916-1919; DOI: https://doi.org/10.3899/jrheum.161105
Louise Klokker
From the Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen,
Denmark; Department of Medicine, School of Epidemiology, Public Health and Community Medicine, University of Ottawa, Ottawa, Ontario; Department of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta,
Canada; Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Division of Immunology and Rheumatology, Stanford University, Stanford, California; David Geffen School of Medicine, Division of Rheumatology, University of California at Los Angeles (UCLA); Healthy Motivation, and Global Alliance for Musculoskeletal Health, Bone and Joint Decade, Santa Barbara, California; Strategic Drug Development, Advisory Services, Quintiles and Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; SDG LLC, Cambridge, Massachusetts,
USA; Institute of Translational Medicine, University of Liverpool, Liverpool,
UK; Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, Amsterdam; Department of Epidemiology and Biostatistics, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam,
the Netherlands; Centre for Health Policy Melbourne School of Population and Global Health, University of Melbourne,
Australia.
Peter Tugwell
Daniel E. Furst
Dan Devoe
Paula Williamson
Caroline B. Terwee
Maria E. Suarez-Almazor
Vibeke Strand
Thasia Woodworth
Amye L. Leong
Niti Goel
Maarten Boers
Peter M. Brooks
Lee S. Simon
Robin Christensen
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 44, Issue 12
1 Dec 2017
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group
Louise Klokker, Peter Tugwell, Daniel E. Furst, Dan Devoe, Paula Williamson, Caroline B. Terwee, Maria E. Suarez-Almazor, Vibeke Strand, Thasia Woodworth, Amye L. Leong, Niti Goel, Maarten Boers, Peter M. Brooks, Lee S. Simon, Robin Christensen
The Journal of Rheumatology Dec 2017, 44 (12) 1916-1919; DOI: 10.3899/jrheum.161105
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group
Louise Klokker, Peter Tugwell, Daniel E. Furst, Dan Devoe, Paula Williamson, Caroline B. Terwee, Maria E. Suarez-Almazor, Vibeke Strand, Thasia Woodworth, Amye L. Leong, Niti Goel, Maarten Boers, Peter M. Brooks, Lee S. Simon, Robin Christensen
The Journal of Rheumatology Dec 2017, 44 (12) 1916-1919; DOI: 10.3899/jrheum.161105